InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.036 0.031 (620%)+
Announcement
Release
19 Aug 2026 5:45PM
Price at Release
$0.005
Full Release
download
Summary
Enlitic, Inc., an AI software company specializing in managing medical imaging data, reported a comprehensive loss of US$7,022,520 for the half-year ended 30 June 2026. Revenues declined by 10.5% to US$1,690,629, while operating expenses decreased to US$7.35 million. The company did not declare any dividends and reported net cash outflows of US$4,086,317 from operating activities. Enlitic raised AUD$15 million through the issuance of CHESS Depository Interests (CDIs) and plans to convert convertible notes into CDIs, which will significantly increase equity. However, there remains a material uncertainty about the company's ability to continue as a going concern.
Key Points
  • Enlitic, Inc. reported a comprehensive loss of US$7,022,520 for the half-year ended 30 June 2026.
  • Revenue for the period was US$1,690,629, down 10.5% compared to the previous year.
  • Enlitic's operating expenses decreased by 15.6% to US$7.35 million.
  • The company focuses on AI software for managing medical imaging data.
  • No dividends were declared during the reporting period.
  • Net cash used in operating activities was US$4,086,317.
  • The company raised AUD$15 million through a CDIs issuance.
  • A material uncertainty exists regarding the company's ability to continue as a going concern.
  • Convertible notes will convert into CDIs, resulting in a significant equity increase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.